Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP), 84591-84592 [2016-28207]
Download as PDF
<![CDATA[
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 81, No. 226 / Wednesday, November 23, 2016 / Notices
assistance and consultation to the
activities within ESRO; and (6)
coordinates, develops, and monitors
implementation of program initiatives.
Senior Executive Compensation and
Performance Activity (CAJQG2). (1)
Provides advisory services, and
technical assistance on pay and
compensation guidelines in accordance
with OPM rules and regulations, HHS
and CDC/ATSDR established pay and
compensation recommendation policies,
and procedures; (2) provides expert
human resources advisory services and
technical assistance support to the CDC
performance review boards and
compensation committees; (3) reviews
actions for statutory and regulatory
compliance; (4) manages strategic
recruitment, relocation, and retention
incentives to facilitate attraction of a
quality, diverse workforce to ensure
accomplishment of the CDC/ATSDR
missions; (5) provides performance
management training for all SES and
Title 42 executives with emphasis on
performance systems, timelines,
supervisory and employee
responsibilities; (6) provides guidance
on establishing performance plans,
conducting mid-year reviews, and
conducting final performance rating
discussions and closing performance
plans; (7) develops and maintains a
standard Department-wide performance
management system and forms for
executives; (8) conducts reviews of SES
performance plans and appraisals and
provides feedback; (9) prepares and
submits SES performance system
certification request to OPM and OMB;
(10) processes performance awards and
performance-based pay adjustments;
(11) provides advice, assistance,
templates and training workshops on
performance award and Presidential
Rank Award requirements; (12) manages
the HHS Executive Development
Program, including developmental
activities, rotational assignments, and
the Candidate Development Program;
and (13) advises on development of
executive succession planning
activities.
Title 42 Staffing and Recruitment
Activity (CAJQG3). (1) Provides
leadership, technical assistance,
guidance, and consultation in the
administration of policies and
procedures for appointment of
individuals through the distinguished
consultants, experts, consultants, and
fellows under Title 42 appointment
authorities; and (2) administers and
manages the Guest Researcher and Oak
Ridge Institute for Science and
Education Program.
Immigration Activity (CAJQG4). (1)
provides technical guidance and visa-
VerDate Sep<11>2014
18:04 Nov 22, 2016
Jkt 241001
assistance for employment based, CDCsponsored visas; (2) administers and
Manages the Exchange Visitor Program;
(3) works closely with the US Office of
Exchange and Cultural Affairs, US
Citizenship and Immigration Services,
US Department of Homeland Security,
US Department of State, Office of the
Secretary/DHHS, and US Department of
Labor) to facilitate immigration
procedures; (4) reviews, processes and
files H–1B, O–1, and Green Card (I–140)
Petitions with the U.S. Citizenship and
Immigration Services; (5) provides
advisory services and guidance on
employment based green card petitions
in the Alien of Extraordinary Ability
category; (6) issues Certificate of
Eligibility for J–1 Exchange Visitor
Status through the Student and
Exchange Visitor Information System to
non US citizens seeking CDC J–1 visa
sponsorship; (7) coordinates and
provides consultations and guidance on
Interested Government Agency Waivers;
(8) provides Immigration Training
Workshops to CDC/ATSDR
Administrative Staff; and (9) determines
the appointment mechanism, legal
status, and work authorizations for non
U.S. citizens through the Visitors
Management System.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2016–28225 Filed 11–22–16; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of Potential
Reviewers To Serve on the Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP) in the National
Center for Injury Prevention and Control
(NCIPC).
The Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel provides advice and
guidance to the Secretary, Department
of Health and Human Services (HHS);
the Director, Centers for Disease Control
and Prevention (CDC), and the
Administrator, Agency for Toxic
Substances and Disease Registry
(ATSDR) regarding the concept review,
scientific and technical merit of grant
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
84591
and cooperative agreement assistance
applications, and contract proposals
relating to the causes, prevention, and
control of diseases, disabilities, injuries,
and impairments of public health
significance; exposure to hazardous
substances in the environment; health
promotion and education; and other
related activities that promote health
and well-being.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of NCIPC SEP
objectives. Reviewers with expertise in
the following research fields for injury
and violence prevention are sought to
serve on the NCIPC SEPs, for research
and evaluation related, but not limited
to: Child abuse and neglect, prescription
drug overdose, intimate partner
violence, motor vehicle injury, older
adult falls, self-directed violence, sexual
violence, traumatic brain injury, youth
sports concussion, and youth violence.
Reviewers with expertise in the
following methodological fields for
injury and violence prevention are also
sought to serve on the CDC SEP for
NCIPC programs: economic evaluation,
etiology, implementation and
translation, intervention research,
policy evaluation, program evaluation,
qualitative research design, quantitative
research design, statistics, and
surveillance.
Members and Chairs shall be selected
by the Secretary, HHS, or other official
to whom the authority has been
delegated, on an ‘‘as needed’’ basis in
response to specific applications being
reviewed with expertise to provide
advice. Members will be selected from
authorities in the various fields of
prevention and control of diseases,
disabilities, and injuries. Members of
other chartered HHS advisory
committees may serve on the panel if
their expertise is required.
Consideration is given to professional
training and background, points of view
represented, and upcoming applications
to be reviewed by the committee.
Information about nominated
potential reviewers will be maintained
in the NCIPC Reviewer and Advisor
Database. The work of reviewers’
appointed to NCIPC SEPS includes the
initial review, discussion, and written
critique and evaluation of applications.
This work will enable the CDC/NCIPC
to fulfill its mission of funding
meritorious research that provides vital
knowledge about underlying risk and
protective factors and strategies for
violence and injury prevention https://
www.cdc.gov/injury/.
The U.S. Department of Health and
Human Services policy stipulates that
E:\FR\FM\23NON1.SGM
23NON1
84592
Federal Register / Vol. 81, No. 226 / Wednesday, November 23, 2016 / Notices
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
appointed to serve on a CDC SEP and
can be full-time employees of the U.S.
Government. Current participation on
CDC federal workgroups or prior
experience serving on another federal
advisory committee does not disqualify
a reviewer, except for service on the
Board of Scientific Counselors, NCIPC.
However, HHS policy is to avoid
excessive individual service on advisory
committees and multiple committee
memberships. Reviewers appointed to
the SEP, CDC are not considered Special
Government Employees, and will not be
required to file financial disclosure
reports.
Nominees interested in serving as a
potential reviewer on a SEP, CDC for
NCIPC programs should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, and email address).
Nomination materials must be
postmarked by March 31, 2017 and sent
by U.S. mail to: NCIPC Extramural
Research Program Office (ERPO):
Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Mailstop F–63, Atlanta, Georgia 30329
or to the ERPO Mailbox NCIPC_ERPO@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
mstockstill on DSK3G9T082PROD with NOTICES
[FR Doc. 2016–28207 Filed 11–22–16; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
18:04 Nov 22, 2016
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women, Centers for Disease
Control and Prevention: Notice of
Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Committee on Breast Cancer
in Young Women, Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS), has been renewed for a
2-year period through June 17, 2018.
For information, contact Temeika L.
Fairley, Ph.D., Designated Federal
Officer, Advisory Committee on Breast
Cancer in Young Women, HHS, CDC,
4770 Buford Highway NE., Mailstop
K52, Atlanta, Georgia 30341, telephone
770/488–4518, fax 770/488–4760.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–28206 Filed 11–22–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–D–4033]
Nonprescription Sunscreen Drug
Products—Format and Content of Data
Submissions; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a
guidance for industry entitled
‘‘Nonprescription Sunscreen Drug
Products—Format and Content of Data
Submissions.’’ This guidance addresses
FDA’s current thinking on the format
and content of information provided to
support a request for a determination
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
whether a nonprescription sunscreen
active ingredient is generally recognized
as safe and effective (GRASE), as
provided under the Federal Food, Drug,
and Cosmetic Act (the FD&C Act), as
amended by the Sunscreen Innovation
Act (SIA).
DATES: Submit either electronic or
written comments on Agency guidances
at any time.
ADDRESSES: You may submit comments
as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public submit the comment as a written/
paper submission and in the manner
detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2015–D–4033 for ‘‘Nonprescription
Sunscreen Drug Products—Format and
Content of Data Submissions; Guidance
for Industry; Availability.’’ Received
comments will be placed in the docket
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 81, Number 226 (Wednesday, November 23, 2016)]
[Notices]
[Pages 84591-84592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-28207]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Potential Reviewers To Serve on the
Disease, Disability, and Injury Prevention and Control Special Emphasis
Panel (SEP)
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the Disease, Disability, and
Injury Prevention and Control Special Emphasis Panel (SEP) in the
National Center for Injury Prevention and Control (NCIPC).
The Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel provides advice and guidance to the Secretary,
Department of Health and Human Services (HHS); the Director, Centers
for Disease Control and Prevention (CDC), and the Administrator, Agency
for Toxic Substances and Disease Registry (ATSDR) regarding the concept
review, scientific and technical merit of grant and cooperative
agreement assistance applications, and contract proposals relating to
the causes, prevention, and control of diseases, disabilities,
injuries, and impairments of public health significance; exposure to
hazardous substances in the environment; health promotion and
education; and other related activities that promote health and well-
being.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of NCIPC
SEP objectives. Reviewers with expertise in the following research
fields for injury and violence prevention are sought to serve on the
NCIPC SEPs, for research and evaluation related, but not limited to:
Child abuse and neglect, prescription drug overdose, intimate partner
violence, motor vehicle injury, older adult falls, self-directed
violence, sexual violence, traumatic brain injury, youth sports
concussion, and youth violence. Reviewers with expertise in the
following methodological fields for injury and violence prevention are
also sought to serve on the CDC SEP for NCIPC programs: economic
evaluation, etiology, implementation and translation, intervention
research, policy evaluation, program evaluation, qualitative research
design, quantitative research design, statistics, and surveillance.
Members and Chairs shall be selected by the Secretary, HHS, or
other official to whom the authority has been delegated, on an ``as
needed'' basis in response to specific applications being reviewed with
expertise to provide advice. Members will be selected from authorities
in the various fields of prevention and control of diseases,
disabilities, and injuries. Members of other chartered HHS advisory
committees may serve on the panel if their expertise is required.
Consideration is given to professional training and background, points
of view represented, and upcoming applications to be reviewed by the
committee.
Information about nominated potential reviewers will be maintained
in the NCIPC Reviewer and Advisor Database. The work of reviewers'
appointed to NCIPC SEPS includes the initial review, discussion, and
written critique and evaluation of applications. This work will enable
the CDC/NCIPC to fulfill its mission of funding meritorious research
that provides vital knowledge about underlying risk and protective
factors and strategies for violence and injury prevention https://www.cdc.gov/injury/.
The U.S. Department of Health and Human Services policy stipulates
that
[[Page 84592]]
committee membership be balanced in terms of points of view represented
and the committee's function. Appointments shall be made without
discrimination on the basis of age, race, ethnicity, gender, sexual
orientation, gender identity, HIV status, disability, and cultural,
religious, or socioeconomic status. Nominees must be U.S. citizens
appointed to serve on a CDC SEP and can be full-time employees of the
U.S. Government. Current participation on CDC federal workgroups or
prior experience serving on another federal advisory committee does not
disqualify a reviewer, except for service on the Board of Scientific
Counselors, NCIPC. However, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Reviewers appointed to the SEP, CDC are not considered Special
Government Employees, and will not be required to file financial
disclosure reports.
Nominees interested in serving as a potential reviewer on a SEP,
CDC for NCIPC programs should submit the following items:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number, and
email address).
Nomination materials must be postmarked by March 31, 2017 and sent
by U.S. mail to: NCIPC Extramural Research Program Office (ERPO):
Centers for Disease Control and Prevention, 1600 Clifton Road NE.,
Mailstop F-63, Atlanta, Georgia 30329 or to the ERPO Mailbox
NCIPC_ERPO@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-28207 Filed 11-22-16; 8:45 am]
BILLING CODE 4163-18-P
